The Bedtime Evidence: A UK Appraisal of CBD for Sleep

Sleep problems are common, and the appeal of a simple bedtime drop is understandable. CBD products are now sold alongside herbal teas and magnesium sprays, often under names that imply rest and calm. Yet the gap between a product's positioning and the clinical evidence is wider than many shoppers assume. This article examines what the research does and does not show, how 'night' formulas complicate the picture, and how UK consumers can make a cautious, evidence-led decision.

What the research can and cannot tell us

CBD has been studied in several areas, but sleep is rarely the primary endpoint in large, well-controlled trials. Much of the stronger evidence relates to epilepsy, where a licensed CBD medicine is used under specialist supervision. Sleep has more often been examined as a secondary outcome in small studies of anxiety, pain or other conditions, with different doses, formulations and populations.

Some trials and observational reports have noted improvements in self-reported sleep, but results are inconsistent. Objective measures such as sleep staging do not always mirror subjective reports. Reviews of the field repeatedly call for larger randomised controlled trials with standardised dosing. That does not mean CBD is without promise; it means the current evidence does not establish CBD as a treatment for insomnia. Anecdotes are not useless, but they are not a substitute for controlled data.

For UK shoppers, the practical conclusion is modest: CBD is not a licensed sleeping tablet, and no product should be treated as a guaranteed remedy. If sleep is severely affected, a high-street product is not the first line of enquiry.

Why 'night' formulas complicate the picture

Products marketed for night-time use often contain more than CBD. Lavender, chamomile, lemon balm, valerian and other botanicals are common, and some products include melatonin. In the UK, melatonin is a prescription-only medicine for most purposes, so shoppers should check labels carefully and ask questions if a product's status is unclear.

Combination products make it difficult to know which ingredient, if any, is responsible for an effect. They also increase the risk of interactions and variability between batches. A product may advertise a total CBD content for the bottle rather than a clear amount per dose, and 'full spectrum' does not automatically mean a meaningful or consistent dose.

The label should state CBD content per millilitre, per drop or per capsule, alongside batch testing information. Shoppers should look for a certificate of analysis and check whether THC is reported. Trace THC is a particular concern for anyone who is drug-tested at work or who drives. The FSA's public list of CBD novel foods is a useful starting point for checking whether a product's extracts are on the authorised pathway, though it is not a guarantee of efficacy.

Dosing and timing: a cautious framework

There is no official UK dose for CBD for sleep. Published studies use a wide range, and individual responses vary. A sensible harm-reduction approach is to start with a low dose from a single-ingredient product, keep everything else stable, and record sleep latency, night-time awakenings and daytime alertness for two weeks. Taking CBD 60 to 90 minutes before bed is a common convention, but the evidence for optimal timing is thin.

Do not combine CBD with alcohol or sedative medicines without advice. If you take prescription medication, speak to a pharmacist or GP, because CBD can affect how some drugs are metabolised. Avoid escalating the dose quickly if the first few nights are unchanged. A diary is more informative than a vague impression, and it helps a clinician if you later seek advice.

When sleep needs a GP rather than a high-street product

Sleep disturbance is not one condition. Persistent insomnia, loud snoring with pauses in breathing, restless legs, chronic pain, low mood, anxiety and medication side effects all require proper assessment. As a rule of thumb, if poor sleep occurs on three or more nights a week for three months or more, or if it affects work, driving or mood, it deserves a GP conversation.

CBD may mask a problem rather than solve it. It is not a substitute for treating sleep apnoea, depression or an underlying pain condition. Pregnant or breastfeeding women, people under 18 and anyone taking multiple medicines should be especially cautious and seek clinical advice.

A shopper's checklist for night products

• Confirm the CBD dose per serving, not just the bottle total.
• List every active ingredient and check its legal status in the UK.
• Look for batch-specific testing and a clear THC result.
• Prefer products that avoid medicinal claims.
• Compare price per milligram of CBD.
• Check the returns policy and whether the retailer provides contact details.

CBD may have a role for some people, but the evidence is not yet strong enough for sweeping promises. A calm, sceptical approach is appropriate: try one variable at a time, keep expectations modest, and treat persistent sleep problems as a clinical matter.